Drug & intervention
atazanavir 50 MG Oral Powder [Reyataz]
RxCUI 1598989
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
ReyatazBN · CureCurrent ID 32764
atazanavir 50 MG [Reyataz]SBDC · CureCurrent ID 58981
atazanavir 200 MG [Reyataz]SBDC · CureCurrent ID 35428
atazanavir 300 MG [Reyataz]SBDC · CureCurrent ID 37009
atazanavir Oral Powder [Reyataz]SBDF · CureCurrent ID 58982
atazanavir Oral Capsule [Reyataz]SBDF · CureCurrent ID 33021
atazanavir 200 MG Oral Capsule [Reyataz]SBD · CureCurrent ID 32997
atazanavir 300 MG Oral Capsule [Reyataz]SBD · CureCurrent ID 37010
Molecular structure
Active ingredient: atazanavirAdvertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.